MYC through miR-17-92 Suppresses Specific Target Genes to Maintain Survival, Autonomous Proliferation, and a Neoplastic State

Handle URI:
http://hdl.handle.net/10754/598926
Title:
MYC through miR-17-92 Suppresses Specific Target Genes to Maintain Survival, Autonomous Proliferation, and a Neoplastic State
Authors:
Li, Yulin; Choi, Peter S.; Casey, Stephanie C.; Dill, David L.; Felsher, Dean W.
Abstract:
The MYC oncogene regulates gene expression through multiple mechanisms, and its overexpression culminates in tumorigenesis. MYC inactivation reverses turmorigenesis through the loss of distinguishing features of cancer, including autonomous proliferation and survival. Here we report that MYC via miR-17-92 maintains a neoplastic state through the suppression of chromatin regulatory genes Sin3b, Hbp1, Suv420h1, and Btg1, as well as the apoptosis regulator Bim. The enforced expression of miR-17-92 prevents MYC suppression from inducing proliferative arrest, senescence, and apoptosis and abrogates sustained tumor regression. Knockdown of the five miR-17-92 target genes blocks senescence and apoptosis while it modestly delays proliferative arrest, thus partially recapitulating miR-17-92 function. We conclude that MYC, via miR-17-92, maintains a neoplastic state by suppressing specific target genes.
Citation:
Li Y, Choi PS, Casey SC, Dill DL, Felsher DW (2014) MYC through miR-17-92 Suppresses Specific Target Genes to Maintain Survival, Autonomous Proliferation, and a Neoplastic State. Cancer Cell 26: 262–272. Available: http://dx.doi.org/10.1016/j.ccr.2014.06.014.
Publisher:
Elsevier BV
Journal:
Cancer Cell
Issue Date:
Aug-2014
DOI:
10.1016/j.ccr.2014.06.014
PubMed ID:
25117713
PubMed Central ID:
PMC4191901
Type:
Article
ISSN:
1535-6108
Sponsors:
We thank members of the Felsher Laboratory for generously providing their suggestions and thoughtful discussions. This work was supported by the NIH R01CA170378 (D.W.F.), U54CA149145 (D.W.F. and D.L.D.), U54CA143907 (D.W.F. and Y.L.), and 1F32CA177139 and 5T32A107290 (S.C.C.) grants; the Leukemia and Lymphoma Society Translational Research grant R6223-07 (D.W.F.); and a King Abdullah University of Science and Technology research grant (D.L.D.).
Appears in Collections:
Publications Acknowledging KAUST Support

Full metadata record

DC FieldValue Language
dc.contributor.authorLi, Yulinen
dc.contributor.authorChoi, Peter S.en
dc.contributor.authorCasey, Stephanie C.en
dc.contributor.authorDill, David L.en
dc.contributor.authorFelsher, Dean W.en
dc.date.accessioned2016-02-25T13:43:51Zen
dc.date.available2016-02-25T13:43:51Zen
dc.date.issued2014-08en
dc.identifier.citationLi Y, Choi PS, Casey SC, Dill DL, Felsher DW (2014) MYC through miR-17-92 Suppresses Specific Target Genes to Maintain Survival, Autonomous Proliferation, and a Neoplastic State. Cancer Cell 26: 262–272. Available: http://dx.doi.org/10.1016/j.ccr.2014.06.014.en
dc.identifier.issn1535-6108en
dc.identifier.pmid25117713en
dc.identifier.doi10.1016/j.ccr.2014.06.014en
dc.identifier.urihttp://hdl.handle.net/10754/598926en
dc.description.abstractThe MYC oncogene regulates gene expression through multiple mechanisms, and its overexpression culminates in tumorigenesis. MYC inactivation reverses turmorigenesis through the loss of distinguishing features of cancer, including autonomous proliferation and survival. Here we report that MYC via miR-17-92 maintains a neoplastic state through the suppression of chromatin regulatory genes Sin3b, Hbp1, Suv420h1, and Btg1, as well as the apoptosis regulator Bim. The enforced expression of miR-17-92 prevents MYC suppression from inducing proliferative arrest, senescence, and apoptosis and abrogates sustained tumor regression. Knockdown of the five miR-17-92 target genes blocks senescence and apoptosis while it modestly delays proliferative arrest, thus partially recapitulating miR-17-92 function. We conclude that MYC, via miR-17-92, maintains a neoplastic state by suppressing specific target genes.en
dc.description.sponsorshipWe thank members of the Felsher Laboratory for generously providing their suggestions and thoughtful discussions. This work was supported by the NIH R01CA170378 (D.W.F.), U54CA149145 (D.W.F. and D.L.D.), U54CA143907 (D.W.F. and Y.L.), and 1F32CA177139 and 5T32A107290 (S.C.C.) grants; the Leukemia and Lymphoma Society Translational Research grant R6223-07 (D.W.F.); and a King Abdullah University of Science and Technology research grant (D.L.D.).en
dc.publisherElsevier BVen
dc.subject.meshCell Proliferationen
dc.subject.meshCell Survivalen
dc.titleMYC through miR-17-92 Suppresses Specific Target Genes to Maintain Survival, Autonomous Proliferation, and a Neoplastic Stateen
dc.typeArticleen
dc.identifier.journalCancer Cellen
dc.identifier.pmcidPMC4191901en
dc.contributor.institutionDivision of Oncology, Department of Medicine and Pathology, Stanford University, Stanford, CA 94305, USA.en
dc.contributor.institutionDepartment of Computer Science, Stanford University, Stanford, CA 94305, USA.en
dc.contributor.institutionDivision of Oncology, Department of Medicine and Pathology, Stanford University, Stanford, CA 94305, USA. Electronic address: dfelsher@stanford.edu.en

Related articles on PubMed

All Items in KAUST are protected by copyright, with all rights reserved, unless otherwise indicated.